Abstract
Objective Dietary selenium (Se) deficiency is associated adverse pregnancy outcomes. We sought to determine the feasibility of: (1) assessing dietary Se consumption via administration of a food frequency questionnaire (FFQ) to pregnant women attending the antenatal clinic of Korle Bu Teaching Hospital (KBTH) in Accra, Ghana and (2) quantifying total Se intake.
Methods In this prospective observational cohort study, participants were recruited via purposive sampling and face-to-face data collection was undertaken using structured FFQs. English-speaking pregnant women who were ≥ 18 years old were eligible to participate. Questions of feasibility were assessed and the average total Se intake in the population was analyzed.
Results One hundred study participants met the inclusion criteria out of 117 eligible. It was feasible to administer the surveys in the clinic waiting room. The average total Se intake in this population of pregnant women was 90.4 μg/day ±50.0 μg, which is higher than the National Institute of Health recommended dietary allowance (RDA) of 60μg/day for pregnant women.
Conclusion FFQ assessment of Se consumption and resource evaluation were deemed feasible in the KBTH setting. Participants reported an average Se intake above the RDA. Future studies can examine the influence of Se intake on pregnancy outcomes.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Travel and resources for this work were funded by the UNC Gillings School of Global Public Health Global Travel Award Scholarship.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
UNC Office of Human Research Ethics Date: 4/19/2022 RE: Notice of IRB Exemption Exemption Category: 2.Survey, interview, public observation Study #: 22-0085
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data will be made available upon reasonable request.
